Navigation Links
Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits

titration to comfort phase. Thereafter pain relief was provided using patient controlled analgesia (PCA) in a dose ratio of 2:1 (M6G:morphine). The secondary data announced today demonstrated again that in the initial phase after surgery the dose of M6G required to titrate patients to comfort was 3 times that required for morphine on a weight basis. However, during the prolonged PCA phase, the ratio was lower (0-24 hours 1.6:1; 24-48 hours 1.4:1). This shows that patients in the M6G group made less demands for pain relief after titration to comfort, as assessed by presses on the PCA button. These data support the hypothesis that M6G has a longer duration of analgesic action than morphine.

EMAIL ALERT: If you wish to unsubscribe please email cenes@cenes.com with your name and email address and we will arrange for your address to be removed or alternatively you can visit our website at http://www.cenes.com/contact/alert.htm and unsubscribe there.

Please arrange for the email address alert@cenes.com to pass though your spam filter.

- ------------------------------------------

IMPORTANT NOTICE.

Confidentiality: This e-mail and its attachments are intended for the above named only and may be confidential. If they have come to you in error you must take no action based on them, nor must you copy or show them to anyone; please reply to this e-mail and highlight the error.

Security Warning: Please note that this e-mail has been created in the knowledge that Internet e-mail is not a 100% secure communications medium. We advise that you understand and observe this lack of security when e-mailing us.

Viruses: Although we have taken steps to ensure that this e-mail and attachments are free from any virus, we advise that in keeping with good computing pra
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
3. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
4. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
5. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
9. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
10. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
11. ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
Post Your Comments:
(Date:7/31/2014)... International plc (NASDAQ: ENDP ) (TSX: ENL) ... an increase of 1 percent compared to second quarter ... of $21 million in the second quarter 2014 compared ... quarter of 2013.  As detailed in the supplemental financial ... ended June 30, 2014 increased by 4 percent to $174 ...
(Date:7/31/2014)... and NOTTINGHAM, England , ... (NASDAQ: CBRX ) today announced that ... have announced a collaboration that will support pharmaceutical ... formulation development stage.  Molecular Profiles, pharmaceutical development services ... drug metabolism and pharmacokinetics (DMPK) to give clients ...
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Marken Expands Miami Regional Logistics Center 2
... (NASDAQ: CADX ), a biopharmaceutical company focused ... use in the hospital setting, announced today the voluntary ... Cadence has notified the U.S. Food and Drug Administration ... OFIRMEV lot number V005710 was initiated due to the ...
... Feb. 6, 2012 TeDan Surgical Innovations , ... of the Phantom Series MIS Anterior Hip Retractor ... system of adjustable surgical arms with attachable retractors, enabling ... table or a surgical assistant. Dr. ...
Cached Medicine Technology:Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 3Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 4New Minimally Invasive Hip Retractor Revolutionizes Anterior Hip Replacement Procedures 2
(Date:7/31/2014)... David Kekich, anti-aging icon and CEO of Age ... the acceptance of his revolutionary approach of extracting ... and then screening thousands of compounds against genetic ... “It took longer than I thought and millions ... Kekich. "Client acceptance is exploding, early clinical trial ...
(Date:7/31/2014)... The North American Colorants Market report ... America with analysis and forecast of volume growth. ... American Colorants Market report, to get an idea ... a glimpse of the segmentation in the North ... tables and figures. , http://www.micromarketmonitor.com/market/americas-colorants-8463333110.html ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... Ovarian Cancer Coalition will be featured in the ... space is being donated by EHE International, an ... care management. The eye-catching window display, designed in ... flip-flops symbolizing women’s footsteps, in a ratio that ...
(Date:7/31/2014)... July 31, 2014 Ohio Presbyterian Retirement ... The Sarah Moore Health Care Center, Inc. (Sarah Moore HCC) ... in ownership control. The not-for-profit Sarah Moore HCC was established ... years, the Sarah Moore HCC has grown and developed an ... , "The Sarah Moore HCC has been an integral part ...
(Date:7/31/2014)... release is available in German . ... baby blues after giving birth. Some even develop full-blown ... A, an enzyme responsible for the breakdown of neurotransmitters ... this condition. In comparison to healthy women, women who ... enzyme in their brains. This was discovered by a ...
Breaking Medicine News(10 mins):Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 2Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 3Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 2Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 3Health News:Monoamine oxidase A: Biomarker for postpartum depression 2Health News:Monoamine oxidase A: Biomarker for postpartum depression 3
... Jan. 26 Virginia S. Bauer, who served as ... Growth and Tourism Commission, and is a Commissioner of ... has been named Senior Vice President at Covenant House, ... and Central America helping homeless youth.A widely respected advocate ...
... With Cleveland ClinicCLEVELAND and ABU DHABI, United Arab Emirates, ... (Abu Dhabi) have appointed Andrew Fishleder, M.D. to hold ... Abu Dhabi.Scheduled to open in 2012, the 360-bed multi-specialty ... the Cleveland Clinic model. The hospital is a vital ...
... twenties and thirties are more likely to develop prostate cancer, ... more than 800 men published in the January issue of ... also found that frequent sexual activity in a man,s forties ... activity in a man,s fifties could offer protection from the ...
... work and dedication to the highest quality of care ... ... 2009 -- Sierra Tucson, a premier treatment center dedicated to ... today announced the achievement of accreditation as a "Hospital" by ...
... Jan. 26 Tripling the level of DHA (docosahexaenoic acid) ... born prematurely improved the neurodevelopment outcome of girls, according to ... the Journal of the American Medical Association (JAMA) . ... infant development that is normally found in mother,s milk and, ...
... Abbott ( NYSE: ABT ) will commence tomorrow, Tuesday, Jan. ... of common stock of Advanced Medical Optics, Inc. (AMO) for ... pursuant to the terms of the Agreement and Plan of ... Acquisition Inc., a wholly owned subsidiary of Abbott, and AMO, ...
Cached Medicine News:Health News:Covenant House Appoints Virginia S. Bauer Senior Vice President 2Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 2Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 3Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 4Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 2Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 3Health News:Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission 2Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 2Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 3Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 4Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 2Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 3
This suture adjuster facilitates post operative suture adjustment of running sutures while decreasing the possibility of suture damage or breakage....
11.5 mm curved hook. Flat serrated handle with polished finish. Overall length: 5.9 inches....
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Medicine Products: